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Abstract
Background: Although the outcomes of health promotion and prevention programmes may depend on the level
of intervention, studies and trials often fail to take it into account. The objective of this work was to develop a
framework within which to consider the implementation of interventions, and to propose a tool with which to
measure the quantity and the quality of activities, whether planned or not, relevant to the intervention under
investigation. The framework and the tool were applied to data from the diet and physical activity promotion
PRALIMAP trial.
Methods: A framework allowing for calculation of an intervention dose in any health promotion programme was
developed. A literature reviews revealed several relevant concepts that were considered in greater detail by a
multidisciplinary working group. A method was devised with which to calculate the dose of intervention planned
and that is actually received (programme-driven activities dose), as well as the amount of non-planned intervention
(non-programme-driven activities dose).
Results: Indicators cover the roles of all those involved (supervisors, anchor personnel as receivers and providers,
targets), in each intervention-related groups (IRG: basic setting in which a given intervention is planned by the
programme and may differ in implementation level) and for every intervention period. All indicators are described
according to two domains (delivery, participation) in two declensions (quantity and quality). Application to
PRALIMAP data revealed important inter- and intra-IRG variability in intervention dose.
Conclusions: A literature analysis shows that the terminology in this area is not yet consolidated and that research
is ongoing. The present work provides a methodological framework by specifying concepts, by defining new
constructs and by developing multiple information synthesis methods which must be introduced from the
programme's conception. Application to PRALIMAP underlined the feasibility of measuring the implementation
level. The framework and the tool can be used in any complex programme evaluation. The intervention doses
obtained could be particularly useful in comparative trials.
Trial registration: PRALIMAP is registered at ClinicalTrials.gov under NCT00814554
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Background
As emphasised by Dusenbury et al. [1] in their review of
the implementation of drug abuse prevention in school
settings, important variations in the implementation of
interventions may arise in health promotion programmes.
Other authors before and after him, more particularly
Dane and Schneider [2] and Durlak et al. [3] emphasised
variation factors, such as those regarding adherence.
Nevertheless, the outcomes of programmes are often
analysed without taking variability of implementation
into account [4]. This can lead to the conclusion that a
programme is ineffective when it has not actually been
implemented as expected ("type III error " according to
Basch et al. [5]). In health promotion programmes, par-
ticularly those conducted within the framework of con-
trolled trials, it is therefore necessary to take into account
the level to which interventions are implemented when
interpreting outcomes. This can be viewed as the dose of
intervention received by the target group. The interven-
tion dose must take into account not only the activities
performed according to the programme's frame of refer-
ence, but also those that were conducted but not planned
[6]. This is particularly relevant in health promotion pro-
grammes concerning topics for which media coverage
may lead to initiatives that are locally driven and inde-
pendent from the planned programme. For example, nu-
trition has been the subject of a national programme in
France since 2001 [7].
The objective of the present work was to build a
framework and to propose a tool with which to measure
the quantity and the quality of health promotion activ-
ities implemented, whether planned or not, related to
the themes of the intervention under investigation. The
framework and the tool used to assess the intervention
dose, were applied to data from the PRALIMAP trial
(PRomotion de l'ALIMentation et de l'Activité Physique,
Additional file 1: Box) [8].
Methods
Development of the framework
A working group was set up. The group (comprising the
authors of the present paper) included specialists in pre-
vention, health promotion and health evaluation.
A literature review also revealed several relevant
concepts that were considered in greater detail by the
working group. Various methods have been proposed
with which to evaluate the process of health promotion
programmes [1,9-17].
Development of the tool
Such programmes are generally implemented in settings
constituting homogeneous intervention groups, during
defined period(s) of intervention. We designate them
“intervention-related groups” (IRG). An IRG is a basic
setting (class, school, hospital, district . . .) in which a given
intervention (education, screening . . .) is planned as part
of the programme and in which programme actors may
have particular practices likely to introduce variations in
the implementation of the activities planned within the
programme's frame of reference and/or in the perform-
ance of unplanned activities (beneficial or harmful in ways
relevant to the programme). For every IRG and every
period of intervention, the process evaluation concerned
two major domains: the delivery of the intervention and
the participation of those involved, each of which was
defined in terms of quantity and quality. Four key ques-
tions are to be answered: how much did providers do? Did
providers do well? Did targets participate? And did targets
participate well?
Three categories of programme actors able to influ-
ence implementation of health promotion programmes
were identified [2]: supervisors, personnel anchors and
targets. Supervisors provide personnel anchors with
what they need to carry out the intervention, and over-
see its implementation. Anchors have two roles: as recei-
vers of training in the intervention by supervisors, and
as providers of the intervention to targets.
Crossing of both domains (delivery, participation) with
both declensions (quantity, quality) gives four levels to
be estimated for each type of programme actors (super-
visor, personnel anchor (receiver and provider), target),
i.e. 16 evaluation objects (Figure 1). In practice, only
12 of the 16 are eligible for the process evaluation be-
cause targets do not perform interventions and super-
visors do not work in the field. So, indicators are
established for every IRG in every period and bracketed in
indicator report sheets.
Testing the tool
The framework and the tool used to assess the interven-
tion dose, were applied to the PRALIMAP trial data
Table 1.
Results and discussion
Results
The framework and tool utilisation includes the follow-
ing stages: identification of IRG, identification of inter-
vention periods, identification and categorisation of
programme actors, construction of indicators, data col-
lection, data analysis and valuation of indicators, scoring,
intervention dose calculation, and finally interpretation
of implementation.
Intervention Related Groups (IRG) identification
The Intervention Related Groups (IRG) must be precisely
identified by the investigator from the programme's incep-
tion. They represent the possible combinations of settings
(for example schools, hospitals, cities, districts) and
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interventions (for example education, care, prevention) as
defined in the programme. A setting intended to benefit
from a particular intervention is referred to as IRG-Active
(IRG-A), otherwise it is described as an IRG-Control
(IRG-C) of the intervention concerned (Table 2).
PRALIMAP 24 high schools (settings) were selected
and three strategies (interventions) were evaluated, to
give 72 IRG, among which 36 were IRG-A and 36
IRG-C.
Intervention periods identification
When a programme is implemented, it is important to
divide it up (particularly if it is long) into manageable
periods in order to reduce the effects of phenomena
affecting those involved, such as tiredness, variations in
the learning process, and changes in personnel.
PRALIMAP Each adolescent benefited of interventions
over two consecutive school years (grades 10 and 11)
corresponding to two periods.
Identification and categorisation of the programme actors
Depending on the programmes, three categories of rele-
vant people (supervisors, anchor personnel, targets) may
or may not be present. The programme investigators
comprehensively oversee the implementation but are not
IRG-A supervisors and must not be so defined.
Anchor personnel receive training/information from
supervisors, and then implement the intervention with
the targets. They are often numerous, IRG-specific and
occupy various posts and hierarchical positions. Infor-
mation about events at anchor level is particularly im-
portant because that is where potential deviations from
a programme's frame of reference originate: deviations
such as not performing or only partially performing
planned activities, and introducing unplanned activities.
Targets benefit from intervention and are the subjects
of outcome measures.
PRALIMAP The supervisors were the PRALIMAP
monitors, the anchors were the high school professionals
(administration staff, teachers, catering professionals,
school nurses . . .) and the targets were the high school
students.
Domains
Declensions
Programme
Actors
Intervention delivery Participation
Intervention dose 
Quantity QualityQuantity Quality
Anchors
personnel:
- Providers:
implementing the 
intervention
- Receivers:
being trained in 
the intervention
Supervisors
Targets Targets
Anchors
personnel:
- Providers:
implementing the 
intervention
- Receivers: being 
trained in the 
intervention
Targets
Anchors
personnel:
- Providers:
implementing the 
intervention
- Receivers: being 
trained in the 
intervention
Targets
Supervisors Supervisors Supervisors
Anchors
personnel:
- Providers:
implementing the 
intervention
- Receivers: being 
trained in the 
intervention
Figure 1 Hierarchical organisation of the 16 key objects of evaluation contributing to intervention dose calculation.
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Table 1 Application and adaptation to the PRALIMAP trial of the intervention dose determination framework
Intervention Related Group (IRG)
identification
24 high schools * 3 strategies = 72 IRG: 36 IRG-A, 36 IRG-C
Intervention periods identification 2 intervention periods = intervention implemented during the grade 10 and 11 school years
Identification and categorisation of the
programme actors
Supervisors: PRALIMAP monitors
Anchor personnel: school professionals (administration staff, teachers, catering professionals,
school nurses, . . .)
Targets: high school students
Indicator development Non-programme-driven activities indicators:
* Developed for the 72 IRG
* Concerned respectively the educational nutritional, screening and environmental activities
performed independently of the PRALIMAP trial
Programme-driven activities indicators:
* Developed for the 36 IRG-A
* Concerned the PRALIMAP activities planned by the frame of reference:
- 12 IRG-Education: indicators investigated the delivery of lectures and collective works on nutrition
and the participation in PRALIMAP meetings
-12 IRG-Screening, indicators investigated the delivery of weight and height data and of the proposition
to participate to adapted overweight care management and the participation of students in group
educational sessions
- 12 IRG-Environmental, indicators investigated the delivery of high school environment improvements
(adapted food and physical activity availability) and participation in PRALIMAP parties
Data collection Data collected before the programme implementation:
* High schools nutritional environment (ex: water drinking fountain, proposed physical activities . . .) :
nutritional surveys participated in by school staff
* Nutritional behaviours : adolescent self-administered questionnaires and anthropometric measures
Data collected during implementation:
* Activities delivery data: activity reports, pupil satisfaction surveys (care management, PRALIMAP
meeting. . .)
* Appreciation of PRALIMAP trial : self administered questionnaire
* Evolution of the offer of school catering and physical activity free equipment and the nutritional
environment close by the high school: nutritional surveys participated in by school staff
Data collectedat the end of the programme:
* Activities delivery, school staff and teenagers’ participation and favouring and limiting factors :
- focus group of staff responsible for interventional strategies (high school professionals, head teachers)
- individual semi-structured interview of the PRALIMAP monitors
- focus group of health professionals intervening with overweight and obese adolescents in high school
screening
- nutritional survey of high school professionals and students
Data analysis and evaluation of
indicators
Indicator report sheets are elaborated for every IRG including:
* Quantitative indicators expressed in the form of mean or percentage (eg : pupils' activity
participation rate)
* Qualitative (literal) indicators (eg : ranges of food proposed in the lunches, delivery or not of activity)
The number of indicator report sheets varied from 3 to 6 according to the high school
assigned strategies (Table 3) :
*IRG–Education : 1 indicator report sheet of non-programme-driven activities + 1 indicator report sheet
of programme-driven activities
*IRG–Education control : 1 indicator report sheet of non-programme-driven activities
*IRG– Screening : 1 indicator report sheet of non-programme-driven activities + 1 indicator report sheet
of programme-driven activities
*IRG–Screening control : 1 indicator report sheet of non-programme-driven activities
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Indicators development
Two types of indicator are required: specific indicators
related to programme-driven activities, and general indica-
tors related to non-programme-driven activities. The latter
may lead to over- or under-estimation of programme-
driven activities due to synergy or antagonism, respectively.
Programme-driven activities indicators were established
for IRG-A, for every period and each of the 16 evaluation
objects (Figure 1). Non-programme-driven activities indi-
cators were developed for every IRG (including IRG-C, if
any), every period, and every evaluation object.
PRALIMAP Non-programme-driven activities indica-
tors were developed for the 72 IRG and concerned the
educational nutritional, screening and environmental ac-
tivities performed independently of the PRALIMAP
trial. Two examples of this type of activities can be
given : eco-citizenship actions around nutrition took
place in some of schools in the frame of the ‘Agenda
21’ plan ; actions (Sport, Wellness, first aid, breakfast,
fruit. . .) has been implemented by some school staffs
during local initiatives such as a ‘health week’.
Programme-driven activities indicators were estab-
lished for the 36 IRG-A and concerned the planned
PRALIMAP activities. Twelve IRG education indicators
investigated the delivery of lectures and collective work
on nutrition and participation in PRALIMAP parties.
Twelve IRG screening indicators investigated the collec-
tion of weight and height data and information about
intention to participate in adapted care management and
the participation of students in group educational ses-
sions. Twelve IRG environment indicators investigated
improvements at high schools (changes in diet and phys-
ical activity available) and participation in PRALIMAP
parties.
Data collection
Data collection relied on regular activity reports and on
quantitative and qualitative investigations.
Activity reports permit monitoring of the quantity of
intervention delivered and of participation in activities.
They must be regularly completed by supervisors and
providers.
Table 1 Application and adaptation to the PRALIMAP trial of the intervention dose determination framework
(Continued)
*IRG–Environment : 1 indicator report sheet of non-programme-driven activities + 1 indicator report sheet
of programme-driven activities
*IRG–Environment control : 1 indicator report sheet of non-programme-driven activities
Score assignment Number of experts:18 (3 groups of 6)
Type and specialty of experts: researchers, field professionals or decision-makers, specialists in diet,
physical activity and\or evaluation, knowing or not the PRALIMAP trial, practicing or not in Lorraine
Region
IRG assigned between the experts: the IRG were fairly and anonymously distributed among the
experts
Individual scoring aid: IT (ExcelW)
Scoring : ranging from 0 to 20 for every period, domain and characteristic in each IRGThreshold
defined for the standard deviation and/or the range: if a standard deviation was higher than 2.5 or a
range higher than 6 was observed, the experts debated and proposed a new notation; discrepant scores
were then preserved.
Taking into account between-group variability: A fictitious high school was created and scored by
the 3 groups
Intervention dose calculation Application of intervention dose formula to assigned scores: Dose=DQt x (mean (DQl, PQt,
PQl)/20)
A group effect has been evidenced thanks to the fictitious high school and required score adjustment
varying from 0.8 to 2.8 points.
Eventually 216 doses (108 per period) were calculated (Table 3).
Table 2 An example of intervention related group (IRG)
identification
Setting 1 Setting 2 Setting 3 IRG
Intervention 1 Yes Yes No 3 IRG :
2 IRG-Active
1 IRG-Control
Intervention 2 No No Yes 3 IRG :
1 IRG-Active
2 IRGs-Control
IRG 2 IRG : 2 IRG: 2 IRG : 6 IRG :
1 IRG-Active 1 IRG-Active 1 IRG-Active 3 IRG-Active
1 IRG-Control 1 IRG-Control 1 IRG-Control 3 IRG-Control
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The quantitative investigation of large target popula-
tions generally involves self-administered questionnaires,
ideally completed at the same time as outcome measure-
ment. It retrospectively assesses what has been done be-
tween two outcomes measurement points.
Qualitative investigation allows for measurement of
delivery and participation and elucidates the interpreta-
tions and points of view of those involved. Collection
methods are generally observation, collective interview
(such as focus groups) and individual interview [3,18,19]
Both types of investigation complement one another and
involve collection of information from the various people
involved for every IRG and every period of intervention.
Data can be collected at various points:
– before programme implementation to provide
information about the initial context
– during implementation, at the end of every period,
to compare (in a concomitant or retrospective way)
the performed activities to planned ones and to
identify performed but not planned activities
– at the end of the programme to assess general
response and satisfaction.
The programme actors involved are the objects and the
sources of information. For example, targets may report
on their own participation and that of anchors.
PRALIMAP Before the programme implementation, nu-
tritional environmental data were collected at high schools
via surveys of the staff. During implementation, delivery
data were included in activity reports. Student satisfaction
with the programme was measured using a self-
administered questionnaire completed at the same time as
outcome measurement and surveys of satisfaction with
specific activities (care management, PRALIMAP party).
Information about changes in school catering and physical
activity supply, availability of free equipment, and the nu-
tritional environment in the neighbourhood of the high
school was assessed with a survey among the high school
professionals. At the end of the programme, data on activ-
ity delivery, and on participation by school staff and stu-
dents were collected by focus groups of staff responsible
for interventional strategies (high school professionals,
head teachers), and by individual semi-structured interview
of PRALIMAP monitors.
Data analysis and valuation indicators
Data analysis allowed for valuation of the indicators devel-
oped. To facilitate the later expertise work, the valued
indicators are bracketed within indicator report sheets.
For every IRG, one or two indicator report sheets were
elaborated, one covering non-programme-driven activities
indicators and the other the programme-driven activities
indicators (if IRG-A). On every indicator report sheet
(Figure 2), indicators were presented by domain, de-
clension, and programmes actors concerned as object
and source of information, for each period of intervention.
PRALIMAP Indicator report sheets were developed for
every IRG and included quantitative indicators expressed in
mean or percentage (eg: pupils' activity participation rate),
qualitative (literal) indicators (eg: ranges of food proposed for
lunches, delivery or not of activity). The number of indicator
report sheets varied from three to six according to the high
school assigned strategies (Table 3) totalling 72 indicator re-
port sheets of non-programme-driven activities indicators
and 36 of programme-driven activities indicators (IRG-A).
Assignment of scores
We used the nominal group technique [20] to reach con-
sensual scores. A score covers an IRG set of programme-
driven or non-programme-driven activities indicators; it is
assigned for every domain / declension and every period
(Figure 2). It is impossible to establish from indicators (in
particular those stemming from a qualitative investigation)
an automatic scoring system. Collective expert techniques
are the best methods in that context [21].
The collective expertise method is multidisciplinary, in-
cluding decision-makers, professionals, researchers, and
specialists in the topic of interest and\or the evaluation.
The experts do not all have to be actively involved in the
programme being assessed. Depending on the number of
IRG concerned and available resources, one or several
groups of at least six experts are constituted so as to
obtain a variety of opinions. The notation sessions are
managed by an independent moderator and take place
in the following way:
– anonymous presentation of the IRG characteristics
to provide the experts with an overview of the
environment in which the programme took place,
– explication of the indicators and indicator report sheets,
– determination of a theoretical range of scores,
– IRG-blind scoring by the experts on an individual
marking aid (IT or paper).
The mean, standard deviation and the range of scores
assigned by the experts are calculated for every domain/
declension and every period. If the standard deviation
and/or the range exceed a previously agreed threshold,
experts debate (under the moderator) in order to explain
the deviations, and to look for a possible consensus. The
debate leads to a second score. Mean scores are then
preserved even in the absence of consensus [22].
When several groups of experts are constituted and in
order to take into account the between-group variability, a
fictitious IRG can be proposed to allow for a calibration.
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First Period add as many columns as the 
number of identified periods Observation
Have the planned activity 1  (please 
name of activity) been implemented ? 
Have the planned activity 2  (please 
name of activity) been implemented ? 
add as many lines as the number of 
identified activites 
 *
 *
Have the activity 1  (please name of 
activity) been produced any 
perceptible change ? 
Have the activity 2  (please name of 
activity) been produced any 
perceptible change ? 
add as many lines as the number of 
identified activites 
 *
 *
 percentage
 percentage
 percentage
*
 percentage
*
 percentage
*
Answers: may be expressed on a 
Likert scale (totally, partially, almost 
not) or in percentage
*
Answers: may be expressed on a 
Likert scale (totally, partially, almost 
not) or in percentage
*
Answers: may be expressed on a 
Likert scale (totally, partially, almost 
not) or in percentage
*
Quantity
Answers:  may be expressed on a 
binary scale (yes/no) or a Likert 
scale (totally, partially, almost not) 
or in percentage
Quantity
As a whole how many anchormen received the 
formation ? 
As a whole how many anchormen implemented 
the activity near the target persons? 
Target persons' information 
As a whole have the planned activities been 
implemented ?  
As a whole how many target persons declared 
having participated? 
As a whole have the planned activities been 
implemented ?  
The delivery of the intervention
Supervisors' information 
As a whole have the planned activities been 
implemented ?  
Indicators
Anchormen' information 
Answers : may be expressed on a 
binary scale (yes/no) or a Likert 
scale (totally, partially, almost not) 
or in percentage
Delivery quantity mark ( /maximal assignable 
mark)
Supervisors' information 
As a whole have the activites been useful?**  
Delivery quality mark ( /maximal assignable 
mark)
The delivery of the intervention
Qualtity
Target persons' information 
Supervisors' information 
As a whole have the objectives been achieved ? 
Anchormen' information 
As a whole have the objectives been achieved ? 
Target persons' information 
Participation in the activities
Participation quality mark ( /maximal 
assignable mark)
Supervisors' information 
Anchormen' information 
Target persons' information 
As a whole have the target persons participated 
well ?  
As a whole how much target persons were 
satisfied with the intervention?**: 
As a whole have the target persons participated 
well ?  
Answers : may be expressed on a 
binary scale (yes/no) or a Likert 
scale (totally, partially, almost not) 
or in percentage
Participation in the activities
Quality 
Answers:  may be expressed on a 
Likert scale (totally, partially, almost 
not) or in percentage
Answers: may be expressed on a 
Likert scale (totally, partially, almost 
not) or in percentage
Answers: may be expressed on a 
Likert scale (totally, partially, almost 
not) or in percentage
Participation quantity mark ( /maximal 
assignable mark)
As a whole how many target person received 
the intervention ? 
Anchormen' information 
As a whole how many target persons received 
the intervention ? 
domain
Declension 
Source of 
information 
Figure 2 Template of indicators report sheet.
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Eventually, four IRG*period non-programme-driven
activities scores and four IRG–A*period programme-
driven activities scores are obtained for every period.
A wrap up debate needs to be performed with all the
experts, in particular if several groups have been consti-
tuted. It allows for discussion of the relevance of scores,
the difficulties encountered and the between-group vari-
ability, and preparation for the formal weighting of
scores to be used for the dose calculations.
PRALIMAP Three groups of six experts were consti-
tuted, comprising:
– researchers, field professionals or decision-makers,
– specialists in food, physical activity and/or
evaluation,
– people familiar or not with the PRALIMAP trial,
– people practising or not in the Lorraine Region.
The experts assigned scores ranging from 0 to 20 for every
period, domain and declension in each of the IRG, distribu-
ted fairly and anonymously among the experts. The scores
were entered on computers, allowing for immediate display
of results. If a standard deviation higher than 2.5 or a range
higher than 6 was observed, the experts debated. A fictitious
high school was created and scored by the three groups.
Intervention dose calculation
The four declensions are not independent but nested:
participation is subject to delivery, and quality is subject
to quantity. In practice, the impact of the quantity of activ-
ity delivery is likely to be decreased by the delivery quality
as well as by the quantity and quality of participation. The
delivery quantity score is therefore weighted by the mean
Table 3 Number and type of IRG and number of indicator report sheets and scores according to the high school and
its assigned PRALIMAP strategies
N° school Strategy Indicator report sheets
Education Screening Environment Non-programme-driven
activities
Programme-driven
activities
Score total / school
1 IRG-C IRG-C IRG-C 3 0 3
2 IRG-A IRG-A IRG-C 3 2 5
3 IRG-A IRG-A IRG-A 3 3 6
4 IRG-A IRG-C IRG-A 3 2 5
5 IRG-A IRG-C IRG-C 3 1 4
6 IRG-A IRG-A IRG-A 3 3 6
7 IRG-A IRG-A IRG-C 3 2 5
8 IRG-C IRG-A IRG-C 3 1 4
9 IRG-A IRG-A IRG-A 3 3 6
10 IRG-C IRG-A IRG-A 3 2 5
11 IRG-A IRG-C IRG-C 3 1 4
12 IRG-C IRG-A IRG-C 3 1 4
13 IRG-C IRG-C IRG-C 3 0 3
14 IRG-A IRG-C IRG-A 3 2 5
15 IRG-C IRG-A IRG-A 3 2 5
16 IRG-C IRG-C IRG-A 3 1 4
17 IRG-A IRG-A IRG-C 3 2 5
18 IRG-A IRG-C IRG-A 3 2 5
19 IRG-C IRG-C IRG-A 3 1 4
20 IRG-C IRG-C IRG-C 3 0 3
21 IRG-C IRG-C IRG-A 3 1 4
22 IRG-C IRG-A IRG-A 3 2 5
23 IRG-A IRG-C IRG-C 3 1 4
24 IRG-C IRG-A IRG-C 3 1 4
12 IRG Education 12 IRG Screening 12 IRG Environment 72 36 108
12 IRG –Control -
Education
12 IRG –Control-
Screening
12 IRG –Control-
Environment
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of the delivery quality scores and of the participation
quantity and quality score, the mean being divided by the
common maximal assignable score.
Thus Dose =DQt × (mean (DQl, PQt, PQl)/mas):
DQt
delivery quantity score
DQl
delivery quality score
PQt
participation quantity score
PQl
participation quality score
mas
common maximal assignable score
Two doses are calculated for every intervention period:
one non-programme-driven activities dose for every IRG
and one programme-driven activities dose for every
IRG-A.
PRALIMAP The formula was applied to scores assigned
to each of the 72 IRG covering the 24 high schools.
Overall, 216 doses (108 per period) were calculated: four
for every IRG-A (a non-programme-driven activities
dose and a programme-driven activities dose for each of
the two periods) and two doses for every IRG-C (a non-
programme-driven activities dose for each of the two
periods).
A group effect revealed by the fictitious high school neces-
sitated score adjustment varying from 0.8 to 2.8 points.
Implementation interpretation
The unit of analysis is the setting. For each setting, clus-
ter characteristics (e.g. geographical zone, socioeconomic
status) and target population characteristics (e.g. sex
ratio, mean age, total number of professionals) were col-
lected. Doses are expressed as means, medians, and dis-
tribution parameters. Doses calculated for an IRG are
assigned to every target person belonging to it. The ana-
lysis allows for dose comparisons between IRG or IRG
clusters as defined in the outcomes analysis plan.
PRALIMAP The twelve mean doses (four for each
of the three PRALIMAP strategies) obtained ranged
from 5.2 (programme-driven activities dose second year
screening) to 9.0 (non-programme-driven activities dose
first year education) (Table 4).
Variability of delivery from one high school to the
other was evidenced for all the strategies; nutritional
educational activities were performed in all the high
schools allocated or not to the education strategy. A few
active high schools performed practically no activity, in
particular for the screening strategy.
The mean doses were low. The programme-driven ac-
tivities mean dose of IRG-education for the first year
was 8.2, while the mean doses of four constituent
declensions / characteristics varied from 11.4 for the
participation quality to 13.6 for the delivery quantity,
with an IRG dose range from 6.5 for participation quan-
tity to 15.8 for delivery quality (Table 5).
The mean dose was higher in the first year than the
second, with the exception of the programme-driven ac-
tivities dose of the environment strategy. The median
was lower than the mean except for environment. Con-
trol high schools had non-null intervention doses that
were weak for the screening strategy (2.7 year 1),
and higher for environment (5.6) and education (6.3).
They benefited from interventions not planned by the
programme. High schools that benefited from a strategy
had doses significantly higher than their controls whatever
Table 4 Global description of the intervention doses in the 24 high schools participating in the PRALIMAP trial
N mean standard deviation median Q1 Q3 min max
Education NPDA* year 1 24 9.0 3.5 8.3 6.6 12.5 3.4 13.9
year 2 24 7.7 2.8 7.8 5.5 10.0 2.5 13.2
PDA** year 1 12 8.2 1.9 7.8 7.3 9.3 4.7 11.8
year 2 12 6.3 3.5 7.5 2.7 8.5 0.5 10.9
Screening NPDA year 1 24 5.2 3.7 5.0 2.3 8.4 0.0 11.9
year 2 24 5.0 3.4 5.4 1.8 7.9 0.0 10.1
PDA year 1 12 6.3 3.5 6.6 3.1 9.3 1.2 10.8
year 2 12 3.6 2.7 3.0 1.9 4.8 0.5 8.8
Environment NPDA year 1 24 6.4 2.3 7.0 5.8 7.8 1.8 9.4
year 2 24 5.7 2.0 6.1 4.6 7.3 1.2 9.6
PDA year 1 12 7.8 1.8 7.6 6.8 8.4 5.2 12.5
year 2 12 8.2 3.1 8.6 6.9 9.7 0.3 12.1
* NPDA : Non-programme-driven activities.
** PDA : Programme-driven activities.
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the year. The general environment dose was significantly
higher in IRG-A education than in IRG-C-education, and
the educational non-programme-driven activities dose in
the second year was significantly higher in IRG-A environ-
ment than IRG-C environment (Table 6).
A significant negative interaction between the educa-
tion and environment strategies emerged (Figure 3).
When education and environment were implemented in
combination, the doses of both were lower than expected
in an additive model. The screening strategy was imple-
mented independently of the other strategies (absence of
interaction).
A multivariate analysis taking into account cluster
characteristics (implementation waves, high school edu-
cation type and geographical zone) and individual char-
acteristics (gender, age, social and occupational status,
BMI) did not modify the results.
Discussion
A framework and a tool allowing for calculation of an im-
plementation dose of programme- or non-programme-
driven activities during health promotion programmes were
elaborated, investigated and validated in a cluster rando-
mized trial. An approach led by the theory necessitated spe-
cification of certain concepts (dose, delivery, participation,
quantity, quality, programme actors, information sources),
definition of new constructs (IRG, period, programme-
driven activities, non-programme-driven activities) and de-
velopment of information synthesis techniques (indicator
report sheets by IRG, collective expertise, practical details
of intervention dose calculation). Application in PRALI-
MAP confirmed the feasibility of the approach, demon-
strated important implementation variability between IRG
and over time, and showed that intervention doses can be
obtained and used in future ‘in treatment’ analysis.
The importance of process in health programmes and
trials has been increasingly recognised in recent decades
and has been the subject of three important reviews
[1-3]. In 1998, Dane and Schneider, reviewed 162 primary
and secondary prevention studies [2]. They emphasised
that failure to consider integrity data, particularly regard-
ing adherence, can compromise the internal validity of
prevention studies. In 2003, Dusenbury et al. [1], analyzed
drug addiction prevention studies performed over a
25-year period. They revealed that poor implementa-
tion may reduce a programme's effectiveness and that
strong methodologies to measure and analyze imple-
mentation should be developed. In 2008, Durlak et al.
[3] reviewed more than 500 articles (the majority of
which were already synthesised in five meta-analyses)
and clearly showed that implementation level affects
the outcomes of health promotion and prevention pro-
grammes. They contributed to the description of fac-
tors that influence implementation, and recommended
implementation data collection, which they consider
an essential feature of programme evaluation.
These three reviews showed that the terminology is
not yet consolidated, probably hindering the dissemin-
ation of data from implementation studies. We used a
pragmatic and general classification that covered the
concepts used in the reviews (Table 7). They sometimes
proposed components not of the same nature, for ex-
ample exposure and programme differentiation. Indeed,
programme differentiation is a peculiar characteristic
that can influence implementation but does not depend
on programme actors, whereas exposure represents the
Table 5 IRG Education – year 1 detail of the mean assigned marks
N mean standard deviation median Q1 Q3 min max
Delivery quantity 12 13.6 1.5 14.2 12.4 14.8 10.5 15.7
Delivery quality 12 12.2 2.6 12.1 10.6 14.5 8.2 15.8
Participation quantity 12 12.2 2.4 12.5 11.2 13.6 6.5 15.2
Participation quality 12 11.4 2 11.2 9.8 12.8 8.7 14.5
Table 6 Mean doses obtained for each of the three PRALIMAP strategies
Dose EDUCATION SCREENING ENVIRONNEMENT
Control Active Control Active Control Active
NPDA PDA NPDA PDA NPDA PDA NPDA PDA NPDA PDA NPDA PDA
Education year 1 6,3 11,7 8,2 9,2 8,8 8,9 7,6 8,2 7,7 9,9 8,7
year 2 6,0 9,5 6,3 8,0 6,2 7,5 6,5 6,8 5,5 8,6 7,2
Screening year 1 6,1 6,4 4,4 6,2 2,7 7,7 6,3 5,5 6,3 4,9 6,3
year 2 5,2 3,7 4,7 3,4 2,5 7,4 3,6 5,2 3,4 4,8 3,8
Environment year 1 5,2 8,0 7,6 7,6 6,4 8,2 6,4 7,4 5,6 7,2 7,8
year 2 4,9 8,9 6,6 7,5 5,7 8,3 5,7 8,0 4,9 6,6 8,2
Bold face values: statistically significant difference of the received dose between the control and the strategy groups.
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amount of the programme delivered. It is not always
easy to distinguish, in papers, what is exactly meant by
adherence, dose or quality. Our classification allows for
a hierarchical organization of four components and thus
for the calculation of what we call the ‘intervention
dose’. These components are obtained by simply answer-
ing four questions: how much did providers do? Did
providers do well? Did targets participate? And did tar-
gets participate well?
Like Dane and Schneider [2], we put the emphasis on
clearly identifying, during the indicator construction
process, the information sources and the various personnel
involved in the programme – each of whom might be a
source of information on the others. For example, in a
school programme, students may assess the teachers’ par-
ticipation and vice versa. That is why we suggest precisely
identifying the people associated with each of the four
components (Figure 1).
As underlined by Durlak et al. [3], no study has reported
100% implementation by providers. The implementation
level depends on supervisors or providers, and varies from
20 to 40% depending on the setting. A supervisor or a pro-
vider operating in several programme settings can even
behave differently in each. So it seems necessary to take
into account the setting- and intervention-specific imple-
mentation level; hence we elaborated the new concept of
IRG. In PRALIMAP, the variety, the number of supervisors
and providers and the potential substitution of individual,
from one school year to the next brought to light the im-
portance of taking into account the period and the IRG.
For the evaluation of an effectiveness trial, this notion is
crucial to understanding of the relation between the imple-
mentation and the outcomes. It is just as important in
health programmes not in the context of a trial in order to
take account of variability and weaken the dilution effect
induced by heterogeneity of settings.
Most studies consider only those activities directly driven
by the programme. Durlak suggests considering the contam-
ination aspect (treatment contamination, usual care, alterna-
tive services) in the level of implementation assessment,
particularly when a control comparative group is used. We
stress that implementation in a specific programme may be
influenced by other concomitant programmes such as na-
tional media campaigns, local programmes or personal
initiatives by those involved in the programme under consid-
eration. Therefore, we distinguished between programme-
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Figure 3 PRALIMAP educational and environmental intervention dose received according to the assigned strategies.
Legrand et al. BMC Medical Research Methodology 2012, 12:146 Page 11 of 14
http://www.biomedcentral.com/1471-2288/12/146
Table 7 Correspondence between the concepts used in this paper and three reviews
Reviews Dane and Schneider [2] Dusenbury et al. [1] Durlak et al. [3]
Legrand et al.
Intervention dose Integrity or Fidelity including 5 components :
exposure, adherence, quality of delivery,
programme differentiation, participant
responsiveness
Fidelity including 5 components:
adherence, dose, quality of delivery,
programme differentiation, participant
responsiveness
Including 8 coas mponents:
Fidelity, Dosage, Quality,
Participant responsiveness,
Programme differentiation,
Contamination,
Programme reach,
Programme modification
Delivery Quantity Exposure Dose Dosage
Fidelity (a k a : adherence or
compliance or integrity, or
faithful replication)
Adherence Adherence
Quality Quality of delivery, Adherence Quality of delivery, Adherence Quality
Participation Quantity Participant responsiveness Participant responsiveness Programme reach
Quality Participant responsiveness Participant responsiveness Participant responsiveness
Participants/ sources of
information
Supervisors Supervisors,
Developers
Facilitators
Anchors personnel
(providers / receivers)
Implementers (receivers) or providers Providers Providers
Targets Participants
IRG / / /
Indicators Non-programme-
driven activities
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Programme-driven
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driven and non-programme-driven activities relevant to the
intervention under investigation.
PRALIMAP showed not only the importance of this
distinction, particularly when estimating the effect of the
intervention, but also the difficulty of distinguishing
whether an activity (for example the delivery of a nutri-
tion course within the curriculum) is performed in the
programme's frame of reference. So, in high schools ac-
tive for a given strategy, the non-programme-driven ac-
tivities scores were higher than in control high schools
when we could have expected them to be equal or even
lower.
It is essential to have in mind the indicators from the
programme inception to be sure to eventually have indi-
cators for every domain, every declension and every per-
son involved; the quality and the sufficiency of the data
collection depend on that. So in PRALIMAP we were not
able to collect data on participation in non-programme-
driven screening activities.
Collective expertise appeared to be the most appropri-
ate method [20,22,23] with which to facilitate dose cal-
culation. In PRALIMAP, the experts underlined the
importance of the first indicator sheet, which acts as a
scoring reference. We observed between-group variabil-
ity in scores thanks to the fictitious high school. To min-
imise variability, we recommend limiting the number of
expert groups and submitting to the experts (without
their knowing) a first indicator sheet corresponding to a
fictitious IRG, which allows for measurement of the
group effect and, if necessary, adjustment of scores.
Application to PRALIMAP confirms our hypothesis of
strong implementation variability between IRG, with de-
viation depending on period and intervention strategy.
Awareness of this variability is necessary in order to esti-
mate the influence of implementation on programme
outcomes [3]. That will be performed in PRALIMAP by
‘on-treatment’ analysis [24], in which the calculated dose
of an IRG will be assigned to each student of that IRG.
It is thus about a dose calculated collectively and not in-
dividually. The variability of the calculated final IRG
dose may depend on the weighting method. The method
we used reflects at best the implementation level in the
target population but tends to reduce the dose measure
variability. The ‘in treatment’ analysis could allow for
validation of the proposed weighting method.
Conclusions
The implementation of complex public health and
health promotion programmes is measurable thanks to
the calculation of an intervention dose. The calculation
is based on the construction of indicators developed
from the conception of the programme and rigorous
data collection on the processes with programme actors
likely to induce variations in the implementation.
Independent collective expert input ensures the valid-
ity of the measure obtained.
The tool can be used in any programme evaluation. It
could be particularly useful in comparative trials and in
studies of the influence of implementation on programme
outcomes. Further developments and researches are needed
to ensures its utility and evaluate its transferability to other
contexts.
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